A. Wade-Evans

发表

Precise epitope mapping of the murine transformation‐associated protein, p53.

J. Jenkins, A. Wade-Evans, 1985, The EMBO journal.

The use of African horse sickness virus VP7 antigen, synthesised in bacteria, and anti-VP7 monoclonal antibodies in a competitive ELISA.

A. Wade-Evans, C. Hamblin, R. O'Hara, 1993, Journal of virological methods.

HIV-1 kills renal tubular epithelial cells in vitro by triggering an apoptotic pathway involving caspase activation and Fas upregulation.

G. Camussi, A. Wade-Evans, L. Biancone, 1998, The Journal of clinical investigation.

VP7 from African horse sickness virus serotype 9 protects mice against a lethal, heterologous serotype challenge.

J. Burroughs, A. Wade-Evans, P. Mertens, 1998, Archives of virology. Supplementum.

Sequence of genome segment 9 of bluetongue virus (serotype 1, South Africa) and expression analysis demonstrating that different forms of VP6 are derived from initiation of protein synthesis at two distinct sites.

A. Wade-Evans, P. Mertens, G. Belsham, 1992, The Journal of general virology.

Cloning and sequencing of cynomolgus macaque CCR3, GPR15, and STRL33: potential coreceptors for HIV type 1, HIV type 2, and SIV.

A. Wade-Evans, C. Javan, A. Jenkins, 2001, AIDS research and human retroviruses.

Identification of a bluetongue virus serotype 1-specific ovine helper T-cell determinant in outer capsid protein VP2.

J. Burroughs, A. Wade-Evans, H. Takamatsu, 1990, Virology.

Sequence analysis and in vitro expression of a cDNA clone of genome segment 5 from bluetongue virus, serotype 1 from South Africa.

Z. Pan, A. Wade-Evans, P. Mertens, 1988, Virus research.

Development of the polymerase chain reaction for the detection of bluetongue virus in tissue samples.

A. Wade-Evans, P. Mertens, C. Bostock, 1990, Journal of virological methods.

HIV-persistent infection and cytokine induction in mesangial cells: a potential mechanism for HIV-associated glomerulosclerosis.

A. Wade-Evans, V. Cantaluppi, L. Biancone, 2000, AIDS.

Mechanisms of protection induced by live attenuated simian immunodeficiency virus

A. Wade-Evans, N. Almond, E. Rud, 2001, Journal of medical primatology.

Cloning and expression analysis of full length mouse cDNA sequences encoding the transformation associated protein p53.

J. Jenkins, A. Wade-Evans, K. Rudge, 1984, Nucleic acids research.

Expression of the major core structural protein (VP7) of bluetongue virus, by a recombinant capripox virus, provides partial protection of sheep against a virulent heterotypic bluetongue virus challenge.

P. Mellor, A. Wade-Evans, H. Takamatsu, 1996, Virology.

The complete sequence of genome segment 8 of bluetongue virus, serotype 1, which encodes the nonstructural protein, NS2.

A. Wade-Evans, 1992, Gene.

Complete nucleotide sequence of RNA segment 3 of bluetongue virus serotype 2 (Ona-A). Phylogenetic analyses reveal the probable origin and relationship with other orbiviruses.

A. Wade-Evans, A. Gould, P. Mertens, 1995, Virus research.

Immunological responses and viral modulatory effects of vaccination with recombinant modified vaccinia virus Ankara (rMVA) expressing structural and regulatory transgenes of simian immunodeficiency virus (SIVmac32H/J5M)

A. Wade-Evans, R. Stebbings, R. Ahmed, 2007, Journal of medical primatology.

Mechanisms of protection induced by attenuated simian immunodeficiency virus.

A. Wade-Evans, R. Stebbings, N. Berry, 2002, Virology.

Specific proliferative T cell responses and antibodies elicited by vaccination with simian immunodeficiency virus Nef do not confer protection against virus challenge.

A. Wade-Evans, T. Hanke, R. Stebbings, 2001, AIDS research and human retroviruses.

Two distinct regions of the murine p53 primary amino acid sequence are implicated in stable complex formation with simian virus 40 T antigen

J. Jenkins, A. Wade-Evans, H. Stürzbecher, 1988, Journal of virology.

Characteristics of a Pathogenic Molecular Clone of an End-Stage Serum-Derived Variant of Simian Immunodeficiency Virus (SIVF359)

G. Learn, J. Mullins, J. Heeney, 2001, Journal of Virology.

The complete nucleotide sequence of genome segment 7 of bluetongue virus, serotype 1 from South Africa.

A. Wade-Evans, 1990, Nucleic acids research.

Vaccination with live attenuated simian immunodeficiency virus for 21 days protects against superinfection.

A. Wade-Evans, R. Stebbings, N. Almond, 2004, Virology.

African horsesickness virus VP7 sub-unit vaccine protects mice against a lethal, heterologous serotype challenge.

J. Burroughs, A. Wade-Evans, P. Mertens, 1997, The Journal of general virology.

Preparation and characterization of new challenge stocks of SIVmac32H J5 following rapid serial passage of virus in vivo

A. Wade-Evans, S. Norley, R. Stebbings, 2007, Journal of medical primatology.

Application of the polymerase chain reaction to the detection of African horse sickness viruses.

A. Wade-Evans, S. Zientara, C. Crucière, 1995, Journal of virological methods.

Proteolytic cleavage of VP2, an outer capsid protein of African horse sickness virus, by species-specific serum proteases enhances infectivity in Culicoides.

P. Mellor, J. Burroughs, A. Wade-Evans, 1995, The Journal of general virology.

Bluetongue virus serotypes 1 and 3 infection in Poll Dorset sheep.

A. Wade-Evans, J. Salt, C. Hamblin, 1998, Australian veterinary journal.